Effect of Time-of-Day Nivolumab and Stereotactic Body Radiotherapy in Metastatic Head and Neck Squamous Cell Carcinoma: A Secondary Analysis of a Prospective Randomized Trial

被引：0
|
作者：
Janopaul-Naylor, J. [1 ]
Boe, L. A. [2 ]
Yu, Y. [1 ]
Sherman, E.
Pfister, D. G. [3 ]
Lee, N. Y. [1 ]
McBride, S. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med Oncol, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3667
引用
收藏
页码：E761 / E761
页数：1
相关论文
共 50 条
  • [31] Predictors of Early Response to Immunotherapy in Head and Neck Cancer: A Secondary Clinical and Radiomic Analysis of a Prospective Randomized Trial with Nivolumab
    Yu, Y.
    Chen, L.
    Riaz, N.
    Kang, J. J.
    Thor, M.
    Veeraraghavan, H.
    Apte, A.
    Tsai, C. J.
    Deasy, J. O.
    Sherman, E.
    Lee, N.
    McBride, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S211 - S211
  • [32] Pooled analysis of nivolumab treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the United States and Germany
    Singh, Prianka
    McDonald, Laura
    Waldenberger, Daniela
    Welslau, Manfred
    von der Heyde, Eyck
    Gauler, Thomas
    Dietz, Andreas
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (11): : 3540 - 3551
  • [33] Cost-effectiveness analysis of nivolumab compared to pembrolizumab in the treatment of recurrent or metastatic squamous cell carcinoma of the head and neck
    Yeh, Justin
    Guddati, Achuta Kumar
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (06): : 1821 - 1826
  • [34] Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck The Phase 2 CheckMate 714 Randomized Clinical Trial
    Harrington, Kevin J.
    Ferris, Robert L.
    Gillison, Maura
    Tahara, Makoto
    Argiris, Athanasios
    Fayette, Jerome
    Schenker, Michael
    Bratland, Ase
    Walker, John W. T.
    Grell, Peter
    Even, Caroline
    Chung, Christine H.
    Redman, Rebecca
    Coutte, Alexandre
    Salas, Sebastien
    Grant, Cliona
    de Azevedo, Sergio
    Soulieres, Denis
    Hansen, Aaron R.
    Wei, Li
    Khan, Tariq Aziz
    Miller-Moslin, Karen
    Roberts, Mustimbo
    Haddad, Robert
    JAMA ONCOLOGY, 2023, 9 (06) : 779 - 789
  • [35] Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control
    Nevens, Daan
    Duprez, Frederic
    Daisne, Jean Francois
    Dok, Ruveyda
    Belmans, Ann
    Voordeckers, Mia
    Van den Weyngaert, Danielle
    De Neve, Wilfried
    Nuyts, Sandra
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 (02) : 171 - 177
  • [36] Association of autoimmunity with survival in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab
    Economopoulou, Panagiota
    Kotsantis, Ioannis
    Papaxoinis, George
    Gavrielatou, Niki
    Anastasiou, Maria
    Pantazopoulos, Anastasios
    Kavourakis, George
    Gkolfinopoulos, Stavros
    Panayiotides, Ioannis
    Delides, Alexandros
    Psyrri, Amanda
    ORAL ONCOLOGY, 2020, 111
  • [37] A PROSPECTIVE RANDOMIZED TRIAL OF METHOTREXATE VERSUS CISPLATIN IN THE TREATMENT OF RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    HONG, WK
    SCHAEFER, S
    ISSELL, B
    CUMMINGS, C
    LUEDKE, D
    BROMER, R
    FOFONOFF, S
    DAOUST, J
    SHAPSHAY, S
    WELCH, J
    LEVIN, E
    VINCENT, M
    VAUGHAN, C
    STRONG, S
    CANCER, 1983, 52 (02) : 206 - 210
  • [38] Efficacy of Nivolumab and Pembrolizumab in Platinum-sensitive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Yamashita, G. A., I
    Okamoto, I. S. A. K. U.
    Ito, T. A. T. S. U. Y. A.
    Tokashiki, K. U. N. I. H. I. K. O.
    Okada, T. A. K. U. R. O.
    Tsukahara, K. I. Y. O. A. K. I.
    ANTICANCER RESEARCH, 2023, 43 (08) : 3679 - 3683
  • [39] Clinical outcome of nivolumab in older and frail patients with recurrent/metastatic head and neck squamous cell carcinoma
    Becherini, Carlotta
    Banini, Marco
    Desideri, Isacco
    Salvestrini, Viola
    Caprara, Luisa
    Scotti, Vieri
    Ganovelli, Michele
    Morelli, Ilaria
    Romei, Andrea
    Livi, Lorenzo
    Bonomo, Pierluigi
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (01)
  • [40] Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report
    Endo, Masashi
    Fukuda, Yukiko
    Okada, Kouhei
    Ogawa, Kazunari
    Nakamura, Michiko
    Takahashi, Satoru
    Kawahara, Masahiro
    Akahane, Keiko
    Nagai, Yoshiaki
    Yamaguchi, Hironori
    Nishino, Hiroshi
    Mori, Harushi
    Shirai, Katsuyuki
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 1345 - 1352
12345